Literature DB >> 31614178

Glucose starvation-induced oxidative stress causes mitochondrial dysfunction and apoptosis via Prohibitin 1 upregulation in human breast cancer cells.

Ganesh Kumar Raut1, Moumita Chakrabarti1, Deepika Pamarthy1, Manika Pal Bhadra2.   

Abstract

In recent years there has been an upsurge in research focusing on reprogramming cancer cells through understanding of their metabolic signatures. Alterations in mitochondrial bioenergetics and impaired mitochondrial function may serve as effective targeting strategies especially in triple-negative breast cancers (TNBCs) where hormone receptors and endocrine therapy are absent. Glucose starvation (GS) of MDA-MB-231 and MCF-7 breast cancer cells showed decrease in mitochondrial Oxygen Consumption Rate (OCR), which was rescuable to control level through addition of exogenous antioxidant N-Acetyl Cysteine (NAC). Mechanistically, GS led to increase in mitochondrial ROS and upregulation of the pleiotropic protein, Prohibitin 1 (PHB1), leading to its dissociation from Dynamin-related protein 1 (DRP1), perturbance of mitochondrial membrane potential (MMP) and triggering of the apoptosis cascade. PHB1 also reduced the invasive and migratory potential of both cell lines. We emphasize that glucose starvation remarkably sensitized the highly glycolytic metastatic TNBC cell line, MDA-MB-231 to apoptosis and decreased its migratory potential. Based on our findings, additional TNBC cell lines can be evaluated and a nutritional paradigm be proposed for anticancer therapy.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis; Dynamin-related protein 1 (DRP1); Glucose starvation (GS); Oxidative stress; Prohibitin 1 (PHB1)

Year:  2019        PMID: 31614178     DOI: 10.1016/j.freeradbiomed.2019.09.020

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  8 in total

Review 1.  Mitochondrial dynamics regulators: implications for therapeutic intervention in cancer.

Authors:  Sanjay Kumar; Rahail Ashraf; Aparna C K
Journal:  Cell Biol Toxicol       Date:  2021-10-18       Impact factor: 6.691

2.  A View on Pathogenesis of ≪Vicious Cancer Progression Cycle≫.

Authors:  Polina Schwartsburd
Journal:  Front Oncol       Date:  2020-04-30       Impact factor: 6.244

3.  C. elegans electrotaxis behavior is modulated by heat shock response and unfolded protein response signaling pathways.

Authors:  Shane K B Taylor; Muhammad H Minhas; Justin Tong; P Ravi Selvaganapathy; Ram K Mishra; Bhagwati P Gupta
Journal:  Sci Rep       Date:  2021-02-04       Impact factor: 4.379

4.  A Starvation-Based 9-mRNA Signature Correlates With Prognosis in Patients With Hepatocellular Carcinoma.

Authors:  Dengliang Lei; Yue Chen; Yang Zhou; Gangli Hu; Fang Luo
Journal:  Front Oncol       Date:  2021-11-26       Impact factor: 6.244

5.  Microarray analysis of breast cancer gene expression profiling in response to 2-deoxyglucose, metformin, and glucose starvation.

Authors:  Rita Aoun; Christopher El Hadi; Roula Tahtouh; Rita El Habre; George Hilal
Journal:  Cancer Cell Int       Date:  2022-03-19       Impact factor: 5.722

6.  Boosting nutrient starvation-dominated cancer therapy through curcumin-augmented mitochondrial Ca2+ overload and obatoclax-mediated autophagy inhibition as supported by a novel nano-modulator GO-Alg@CaP/CO.

Authors:  Xuan Wang; Yunhao Li; Fan Jia; Xinyue Cui; Zian Pan; Yan Wu
Journal:  J Nanobiotechnology       Date:  2022-05-12       Impact factor: 9.429

7.  Mitochondrial Ca2+ Uptake Drives Endothelial Injury By Radiation Therapy.

Authors:  Karima Ait-Aissa; Olha M Koval; Nathanial R Lindsey; Isabella M Grumbach
Journal:  Arterioscler Thromb Vasc Biol       Date:  2022-07-28       Impact factor: 10.514

Review 8.  Mitocans Revisited: Mitochondrial Targeting as Efficient Anti-Cancer Therapy.

Authors:  Lanfeng Dong; Vinod Gopalan; Olivia Holland; Jiri Neuzil
Journal:  Int J Mol Sci       Date:  2020-10-26       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.